OncLive |
Polycythemia Vera: Controlling HCT and WBC
OncLive They did a study in patients with PV who were on phlebotomy therapy and low-dose aspirin, and many of them—over half of them—were getting hydroxyurea, as well. They randomized them into 2 populations: a population that had tight control of the ... |
from phlebotomy - Google News http://bit.ly/2O2qnD3
No comments:
Post a Comment